RP Cure Tracker

Trials / NCT00078091

Genetics and Clinical Characteristics of Bardet-Biedl Syndrome

Terminated Observational Natural history / observational

Sponsor
National Human Genome Research Institute (NHGRI)
Treatment
Not listed
Gene
Not stated
Conditions
Bardet-Biedl Syndrome
Ages
Any to no upper limit
Enrollment
194 participants
Started
2004-02-17
Main results expected
Not stated
Results posted
Not yet
Record last updated
2019-12-04

What the study is testing

This study will evaluate patients with a rare inherited condition called Bardet-Biedl syndrome . The purpose of the study is to learn more about the genetics and clinical characteristics of this disorder. Patients may have the following problems: polydactyly (extra fingers and toes); retinal dystrophy (changes in the retina that may lead to vision problems, including blindness); obesity and diabetes (overweight and high blood sugar due to failure of body organs to respond to insulin); cognitive dysfunction (difficulties with learning and understanding); hypogenitalism (decreased functioning of the ovaries in women and the testes in men); kidney anomalies (changes in the structure or function of the kidneys); heart disease; and hepatic fibrosis (liver disease).

Patients with Bardet-Biedl syndrome may be eligible for this study. First-degree relatives will also be enrolled for certain tests and procedures. Candidates are screened with a review of their medical records, laboratory tests, and x-rays.

Patients in this study undergo the following tests and procedures:

Relatives of patients have a complete medical and family history and physical examination. Blood is drawn for assessment of kidney, liver, heart, and hormonal function and for genetic study and other research purposes. Relatives over 5 years of age may have tests of learning ability and cognition. For younger patients, a parent is asked about the child's development. Relatives meet with investigators and a genetic counselor for review of test findings when the studies are completed.

Where it runs

United States (1)

Open on ClinicalTrials.gov for contacts and eligibility